DiscoverThriller & Suspense



Worth reading 😎

Tropannos promises extraordinary healing properties, so much so that medical powers that be must kill to protect the state quo

The plot of this book centers on Tropannos, a biofilm-destroying agent with extraordinary healing properties. The theme is the inertia of the status quo as played out through a vaguely described governmental or corporate organization that has too much invested in today’s world to allow epochal changes (presumably for the better) to occur.

The protagonist, Kevin, appears initially as a failed lawyer, unfairly discharged from his firm for pursuing a suit against the government to establish a flat tax using the argument that the Constitution does not allow ‘unfair’ taxation. His friend-to-be, Ben, rescues him from a drunken stumble into traffic, and the friendship begins. Kevin is hired into a large medical organization to be a salesman for their intravenous infusion and respiratory devices. At a company meeting, a representative of another large company talks up the biological preparation called Tropannos. 

Kevin sees potential in Tropannos and begins convincing various infusion clients to try it on patients in long-term care. Through this effort he meets a dentist who comes to believe in the drug’s power and sees successes in which Tropannos succeeds in healing antibiotic-resistant wounds. 

The story centers around Kevin, his friend Ben, and their ladies, Diane Lane (Kevin) and Justine Maxwell (Ben). There is quite a bit of interplay between the couples, and we see Kevin’s growing love for Diane, cemented by an injury she suffers on a business trip. 

The plot develops slowly and initially concerns both the flat tax issue and Tropannos. The flat tax issue peters out after deep research by a personable robot. Kevin is well-drawn, but his moral compass drifts toward expediency and financial success, which makes him something of an anti-hero. The theme is not apparent early on, primarily because neither the flat tax issue nor Tropannos seem to be credible challenges to the status quo. Tropannos is clearly a drug, yet the FDA, clinical trials, or phased approval are never mentioned, which make Kevin’s activity with it criminal and thus hard for the reader to root for its success. 

Tropannos is potentially interesting story in the vein of Michael Crichton and Dean Koontz. It has major problems in structure and technique. The central challenge is vague, develops slowly, and has little impact on the main characters, so it is hard to see the rising tension that usually grips the reader in this form of mystery. And the writing needs work. The misuse of words, spelling errors and grammatical challenges occur often enough to make the reader pause. Copyediting could solve these issues, but the larger problem is in technique. Sentence structure, inadvertent changes in POV, and the repetitive use of action verbs in dialog tags (rather than ‘said’) are speedbumps to reading.

Reviewed by


About the author

A former criminal investigator, and current executive in the medical industry, I have been privy to many things the average person is not. Although I could write in nonfiction, I am a born fiction writer who is able to convey my world into compelling fiction novels that inspire, educate, and warn. view profile

Published on September 30, 2022

70000 words

Contains mild explicit content ⚠️

Genre: Thriller & Suspense

Reviewed by